Researchers have developed a novel hydrogen-assisted transplantation strategy to overcome the significant challenges of cell death and phenotype loss in osteoarthritis treatment. By synthesizing titanium silicide (TSN) nanosheets, the team created a delivery system capable of providing a sustained two-month supply of hydrogen molecules directly to damaged joints. This persistent hydrogen release effectively neutralizes the toxic inflammatory microenvironment, preserving the health and functionality of transplanted chondrocyte microspheroids. In large-animal sheep models, this advanced H-MACsT therapy achieved remarkable results, including near-total cartilage regeneration and a successful reversal of disease progression within six months. The study demonstrates that hydrogen’s antioxidant and anti-inflammatory properties are vital for maintaining the survival of stem cell-derived grafts in pathological conditions. Consequently, this innovative approach offers a promising clinical pathway for treating refractory joint diseases and improving long-term success rates in regenerative medicine.

References:

• Chen S, Luo M, Chen S, et al. Preservation of chondrocyte microspheroids by local sustained hydrogen supply improves osteoarthritic cartilage repair[J]. Cell Stem Cell, 2026.